메뉴 건너뛰기




Volumn 9, Issue 6, 2012, Pages 671-680

Overview, hurdles, and future work in adaptive designs: Perspectives from a National Institutes of Health-funded workshop

Author keywords

[No Author keywords available]

Indexed keywords

UBIDECARENONE;

EID: 84871838300     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774512461859     Document Type: Conference Paper
Times cited : (55)

References (38)
  • 1
    • 33646245937 scopus 로고    scopus 로고
    • Adaptive designs in clinical drug development-An executive summary of the PhRMA working group
    • Gallo P, Chuang-Stein C, Dragalin V, et al. Adaptive designs in clinical drug development-An executive summary of the PhRMA working group. J Biopharm Stat. 2006 ; 16: 275-83
    • (2006) J Biopharm Stat , vol.16 , pp. 275-283
    • Gallo, P.1    Chuang-Stein, C.2    Dragalin, V.3
  • 3
    • 36249017451 scopus 로고    scopus 로고
    • Adaptive designs in clinical drug development: Opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop
    • DOI 10.1080/10543400701643764, PII 785294562
    • Krams M, Burman CF, Dragalin V, et al. Adaptive designs in clinical drug development: Opportunities, challenges, and scope reflections following PhRMA's November 2006 workshop. J Biopharm Stat. 2007 ; 17: 957-64 (Pubitemid 350135823)
    • (2007) Journal of Biopharmaceutical Statistics , vol.17 , Issue.6 , pp. 957-964
    • Krams, M.1    Burman, C.-F.2    Dragalin, V.3    Gaydos, B.4    Grieve, A.P.5    Pinheiro, J.6    Maurer, W.7
  • 4
    • 44949171503 scopus 로고    scopus 로고
    • Adaptive design methods in clinical trials-A review
    • Chow SC, Chang M. Adaptive design methods in clinical trials-A review. Orphanet J Rare Dis. 2008 ; 3: 11
    • (2008) Orphanet J Rare Dis , vol.3 , pp. 11
    • Chow, S.C.1    Chang, M.2
  • 5
    • 46349091495 scopus 로고    scopus 로고
    • Adaptive Clinical Trials: Progress and Challenges
    • DOI 10.2165/00126839-200809040-00003
    • Coffey CS, Kairalla JA. Adaptive clinical trials: Progress and challenges. Drugs R D. 2008 ; 9 (4). 229-42 (Pubitemid 351920122)
    • (2008) Drugs in R and D , vol.9 , Issue.4 , pp. 229-242
    • Coffey, C.S.1    Kairalla, J.A.2
  • 7
  • 8
    • 33750854903 scopus 로고    scopus 로고
    • Adaptive designs: Terminology and classification
    • Dragalin V. Adaptive designs: Terminology and classification. Drug Inf J. 2006 ; 40: 425-35 (Pubitemid 44721120)
    • (2006) Drug Information Journal , vol.40 , Issue.4 , pp. 425-435
    • Dragalin, V.1
  • 9
    • 77954875817 scopus 로고    scopus 로고
    • Food and Drug Administration Draft guidance (accessed 7 July 2010)
    • Food and Drug Administration. Guidance for industry: Adaptive design clinical trials for drugs and biologics, 2010. Draft guidance. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM201790.pdf (accessed 7 July 2010).
    • (2010) Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics
  • 11
    • 33644597596 scopus 로고    scopus 로고
    • The continual reassessment method for dose-finding studies: A tutorial
    • Garrett-Mayer E. The continual reassessment method for dose-finding studies: A tutorial. Clin Trials. 2006 ; 3: 57-71
    • (2006) Clin Trials , vol.3 , pp. 57-71
    • Garrett-Mayer, E.1
  • 13
    • 0242694372 scopus 로고    scopus 로고
    • ASTIN: An adaptive dose-response study of UK-279,276 in acute ischemic stroke
    • Krams M, Lees KR, Hacke W, et al. ASTIN: An adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke. 2003 ; 34: 2543-49
    • (2003) Stroke , vol.34 , pp. 2543-2549
    • Krams, M.1    Lees, K.R.2    Hacke, W.3
  • 15
    • 66349125688 scopus 로고    scopus 로고
    • Adaptive patient enrichment designs in therapeutic trials
    • Wang SJ, Hung HMJ, O'Neill RT. Adaptive patient enrichment designs in therapeutic trials. Biom J. 2009 ; 51: 358-74
    • (2009) Biom J , vol.51 , pp. 358-374
    • Wang, S.J.1    Hmj, H.2    O'Neill, R.T.3
  • 16
    • 78449283356 scopus 로고    scopus 로고
    • Enrichment of clinical study populations
    • Temple R. Enrichment of clinical study populations. Clin Pharmacol Ther. 2010 ; 88: 774-78
    • (2010) Clin Pharmacol Ther , vol.88 , pp. 774-778
    • Temple, R.1
  • 17
    • 84859224484 scopus 로고    scopus 로고
    • Potential of adaptive clinical trial designs in pharmacogenetic research
    • Van der Baan FH, Knol MJ, Klungel OH, et al. Potential of adaptive clinical trial designs in pharmacogenetic research. Pharmacogenomics. 2012 ; 13: 571-78
    • (2012) Pharmacogenomics , vol.13 , pp. 571-578
    • Van Der Baan, F.H.1    Knol, M.J.2    Klungel, O.H.3
  • 18
    • 84864238949 scopus 로고    scopus 로고
    • Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo controlled trial using a novel adaptive enrichment design
    • Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo controlled trial using a novel adaptive enrichment design. Cephalagia. 2012 ; 10: 750-65
    • (2012) Cephalagia , vol.10 , pp. 750-765
    • Ho, T.W.1    Pearlman, E.2    Lewis, D.3
  • 19
    • 78249272973 scopus 로고    scopus 로고
    • Adaptive methods: Telling 'The Rest of the Story'
    • Emerson SS, Fleming TR. Adaptive methods: Telling 'The Rest of the Story'. J Biopharm Stat. 2010 ; 20: 1150-65
    • (2010) J Biopharm Stat , vol.20 , pp. 1150-1165
    • Emerson, S.S.1    Fleming, T.R.2
  • 20
    • 66349091397 scopus 로고    scopus 로고
    • Sample size re-estimation in clinical trials
    • Proschan MA. Sample size re-estimation in clinical trials. Biom J. 2009 ; 51: 348-57
    • (2009) Biom J , vol.51 , pp. 348-357
    • Proschan, M.A.1
  • 21
    • 1842826262 scopus 로고    scopus 로고
    • On the inefficiency of the adaptive design for monitoring clinical trials
    • DOI 10.1093/biomet/90.2.367
    • Tsiatis AA, Mehta C. On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika. 2003 ; 90: 367-78 (Pubitemid 39047164)
    • (2003) Biometrika , vol.90 , Issue.2 , pp. 367-378
    • Tsiatis, A.A.1    Mehta, C.2
  • 22
    • 82055200248 scopus 로고    scopus 로고
    • Adaptive increase in sample size when interim results are promising: A practical guide with examples
    • Mehta C, Pocock SJ. Adaptive increase in sample size when interim results are promising: A practical guide with examples. Stat Med. 2011 ; 30: 3267-84
    • (2011) Stat Med , vol.30 , pp. 3267-3284
    • Mehta, C.1    Pocock, S.J.2
  • 23
    • 22044443101 scopus 로고    scopus 로고
    • Two-stage sample size re-estimation based on a nuisance parameter: A review
    • DOI 10.1081/BIP-200062852
    • Proschan MA. Two-stage sample size re-estimation based on a nuisance parameter: A review. J Biopharm Stat. 2005 ; 15: 559-74 (Pubitemid 40967299)
    • (2005) Journal of Biopharmaceutical Statistics , vol.15 , Issue.4 , pp. 559-574
    • Proschan, M.A.1
  • 24
    • 33748550685 scopus 로고    scopus 로고
    • Sample size recalculation in Internal pilot study designs: A review
    • DOI 10.1002/bimj.200510238
    • Friede T, Kieser M. Sample size recalculation in internal pilot study designs: A review. Biom Journal. 2006 ; 4: 537-55 (Pubitemid 44367892)
    • (2006) Biometrical Journal , vol.48 , Issue.4 , pp. 537-555
    • Friede, T.1    Kieser, M.2
  • 25
    • 0033619975 scopus 로고    scopus 로고
    • Internal pilot studies II: Comparison of various procedures
    • DOI 10.1002/(SICI)1097-0258(1999 1230)18:24<3493::AID-SIM302>3. 0.CO;2-2
    • Zucker DM, Wittes JT, Schabenberger O, et al. Internal pilot studies II: Comparison of various procedures. Stat Med. 1999 ; 18: 3493-509 (Pubitemid 30041362)
    • (1999) Statistics in Medicine , vol.18 , Issue.24 , pp. 3493-3509
    • Zucker, D.M.1    Wittes, J.T.2    Schabenberger, O.3    Brittain, E.4
  • 26
    • 33750854113 scopus 로고    scopus 로고
    • Adaptive seamless phase II/III designs - Background, operational aspects, and examples
    • Maca J, Bhattacharya S, Dragalin V, et al. Adaptive seamless phase II/III designs: Background operational aspects and examples. Drug Inf J. 2006 ; 40: 463-73 (Pubitemid 44721124)
    • (2006) Drug Information Journal , vol.40 , Issue.4 , pp. 463-473
    • Maca, J.1    Bhattacharya, S.2    Dragalin, V.3    Gallo, P.4    Krams, M.5
  • 27
    • 84555178552 scopus 로고    scopus 로고
    • Seamless phase II/III designs
    • Stallard N, Todd S. Seamless phase II/III designs. Stat Methods Med Res. 2010 ; 20: 623-34
    • (2010) Stat Methods Med Res , vol.20 , pp. 623-634
    • Stallard, N.1    Todd, S.2
  • 28
    • 70249116820 scopus 로고    scopus 로고
    • Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
    • Kaufmann P, Thompson JLP, Levy G, et al. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol. 2009 ; 66: 235-44
    • (2009) Ann Neurol , vol.66 , pp. 235-244
    • Kaufmann, P.1    Jlp, T.2    Levy, G.3
  • 29
    • 80051695379 scopus 로고    scopus 로고
    • Statistical aspects of the TNK-S2B trial of Tenecteplase versus Alteplase in acute ischemic stroke: An efficient, dose-adaptive, seamless phase II/III design
    • Levin B, Thompson JLP, Chakraborty B, et al. Statistical aspects of the TNK-S2B trial of Tenecteplase versus Alteplase in acute ischemic stroke: An efficient, dose-adaptive, seamless phase II/III design. Clin Trials. 2011 ; 8: 398-407
    • (2011) Clin Trials , vol.8 , pp. 398-407
    • Levin, B.1    Jlp, T.2    Chakraborty, B.3
  • 30
    • 33845891920 scopus 로고    scopus 로고
    • The design of simulation studies in medical statistics
    • DOI 10.1002/sim.2673
    • Burton A, Altman DG, Royston P, et al. The design of simulation studies in medical statistics. Stat Med. 2006 ; 25: 4279-92 (Pubitemid 46023772)
    • (2006) Statistics in Medicine , vol.25 , Issue.24 , pp. 4279-4292
    • Burton, A.1    Altman, D.G.2    Royston, P.3    Holder, R.L.4
  • 32
    • 33750884934 scopus 로고    scopus 로고
    • Confidentiality and trial integrity issues for adaptive designs
    • Gallo P. Confidentiality and trial integrity issues for adaptive designs. Drug Inf J. 2006 ; 4: 445-50
    • (2006) Drug Inf J , vol.4 , pp. 445-450
    • Gallo, P.1
  • 33
    • 70350139975 scopus 로고    scopus 로고
    • Good practices for adaptive clinical trials in pharmaceutical product development
    • Gaydos B, Anderson KB, Berry D, et al. Good practices for adaptive clinical trials in pharmaceutical product development. Drug Inf J. 2009 ; 43: 539-56
    • (2009) Drug Inf J , vol.43 , pp. 539-556
    • Gaydos, B.1    Anderson, K.B.2    Berry, D.3
  • 34
    • 84863475669 scopus 로고    scopus 로고
    • On the independence of data monitoring committees in adaptive design clinical trials
    • Chow SC, Corey R, Lin M. On the independence of data monitoring committees in adaptive design clinical trials. J Biopharm Stat. 2012 ; 22: 853-67
    • (2012) J Biopharm Stat , vol.22 , pp. 853-867
    • Chow, S.C.1    Corey, R.2    Lin, M.3
  • 35
    • 33750893179 scopus 로고    scopus 로고
    • Implementing adaptive designs: Logistical and operational considerations
    • Quinlan JA, Krams M. Implementing adaptive designs: Logistical and operational considerations. Drug Inf J. 2006 ; 40: 437-44 (Pubitemid 44721121)
    • (2006) Drug Information Journal , vol.40 , Issue.4 , pp. 437-444
    • Quinlan, J.A.1    Krams, M.2
  • 36
    • 77953666447 scopus 로고    scopus 로고
    • Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development
    • Quinlan J, Gaydos B, Maca J, et al. Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development. Clin Trials. 2010 ; 7: 167-73
    • (2010) Clin Trials , vol.7 , pp. 167-173
    • Quinlan, J.1    Gaydos, B.2    MacA, J.3
  • 37
    • 84856000206 scopus 로고    scopus 로고
    • NeuroNEXT: Accelerating drug development in neurology
    • NeuroNEXT: Accelerating drug development in neurology. Lancet Neurol. 2012 ; 11: 119
    • (2012) Lancet Neurol , vol.11 , pp. 119
  • 38
    • 84866735197 scopus 로고    scopus 로고
    • An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project
    • Meurer WJ, Lewis RJ, Tagle D, et al. An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project. Ann Emerg Med. 2012 ; 60: 451-57
    • (2012) Ann Emerg Med , vol.60 , pp. 451-457
    • Meurer, W.J.1    Lewis, R.J.2    Tagle, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.